Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $76.8 million.

  • Integra Lifesciences Holdings' Shares Outstanding (Diluted Average) fell 57.39% to $76.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.8 million, marking a year-over-year decrease of 57.39%. This contributed to the annual value of $77.0 million for FY2024, which is 414.13% down from last year.
  • As of Q3 2025, Integra Lifesciences Holdings' Shares Outstanding (Diluted Average) stood at $76.8 million, which was down 57.39% from $76.7 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Shares Outstanding (Diluted Average) ranged from a high of $85.5 million in Q4 2021 and a low of $76.5 million during Q1 2025
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $81.7 million (2023), whereas its average is $81.1 million.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Shares Outstanding (Diluted Average) surged by 30.15% in 2021 and then plummeted by 557.32% in 2024.
  • Over the past 5 years, Integra Lifesciences Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $85.5 million in 2021, then decreased by 2.3% to $83.5 million in 2022, then dropped by 3.81% to $80.3 million in 2023, then fell by 4.14% to $77.0 million in 2024, then fell by 0.33% to $76.8 million in 2025.
  • Its last three reported values are $76.8 million in Q3 2025, $76.7 million for Q2 2025, and $76.5 million during Q1 2025.